Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2001 3
2002 1
2003 3
2004 3
2005 3
2006 8
2007 9
2008 6
2009 9
2010 8
2011 17
2012 15
2013 13
2014 12
2015 25
2016 4
2017 11
2018 4
2019 3
2020 9
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21989469

158 results
Results by year
Filters applied: . Clear all
Page 1
Cost-effectiveness of the use of low- and high-potency statins in people at low cardiovascular risk.
Conly J, Clement F, Tonelli M, Hemmelgarn B, Klarenbach S, Lloyd A, McAlister FA, Husereau D, Wiebe N, Au F, Manns B; Alberta Kidney Disease Network. Conly J, et al. CMAJ. 2011 Nov 8;183(16):E1180-8. doi: 10.1503/cmaj.101281. Epub 2011 Oct 11. CMAJ. 2011. PMID: 21989469 Free PMC article.
Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
Kang HY, Ko SK, Liew D. Kang HY, et al. Clin Ther. 2009 Dec;31(12):2919-30; discussion 2916-8. doi: 10.1016/j.clinthera.2009.12.013. Clin Ther. 2009. PMID: 20110032
Cost-effectiveness of intensive lipid lowering therapy with 80 mg of atorvastatin, versus 10 mg of atorvastatin, for secondary prevention of cardiovascular disease in Canada.
Wagner M, Goetghebeur M, Merikle E, Pandya A, Chu P, Taylor DC. Wagner M, et al. Can J Clin Pharmacol. 2009 Summer;16(2):e331-45. Epub 2009 Jun 16. Can J Clin Pharmacol. 2009. PMID: 19531812
Cost-effectiveness of statins in the prevention of coronary heart disease events in middle-aged Finnish men.
Peura P, Martikainen J, Soini E, Hallinen T, Niskanen L. Peura P, et al. Curr Med Res Opin. 2008 Jun;24(6):1823-32. doi: 10.1185/03007990802144705. Epub 2008 May 15. Curr Med Res Opin. 2008. PMID: 18485270
Cost-effectiveness of statins for primary prevention in patients newly diagnosed with type 2 diabetes in the Netherlands.
de Vries FM, Denig P, Visser ST, Hak E, Postma MJ. de Vries FM, et al. Value Health. 2014 Mar;17(2):223-30. doi: 10.1016/j.jval.2013.12.010. Value Health. 2014. PMID: 24636380 Free article.
Prescribing high-dose lipid-lowering therapy early to avoid subsequent cardiovascular events: is this a cost-effective strategy?
Ara R, Pandor A, Stevens J, Rafia R, Ward SE, Rees A, Durrington PN, Reynolds TM, Wierzbicki AS, Stevenson M. Ara R, et al. Eur J Prev Cardiol. 2012 Jun;19(3):474-83. doi: 10.1177/1741826711406616. Epub 2011 Apr 1. Eur J Prev Cardiol. 2012. PMID: 21460076
Incremental benefit and cost-effectiveness of high-dose statin therapy in high-risk patients with coronary artery disease.
Chan PS, Nallamothu BK, Gurm HS, Hayward RA, Vijan S. Chan PS, et al. Circulation. 2007 May 8;115(18):2398-409. doi: 10.1161/CIRCULATIONAHA.106.667683. Epub 2007 Apr 23. Circulation. 2007. PMID: 17452609
Cost-effectiveness of rosuvastatin 20 mg for the prevention of cardiovascular morbidity and mortality: a Swedish economic evaluation of the JUPITER trial.
Ohsfeldt RL, Olsson AG, Jensen MM, Gandhi SK, Paulsson T. Ohsfeldt RL, et al. J Med Econ. 2012;15(1):125-33. doi: 10.3111/13696998.2011.627073. Epub 2011 Nov 4. J Med Econ. 2012. PMID: 22050473
Cost-effectiveness of high-dose atorvastatin compared with regular dose simvastatin.
Lindgren P, Graff J, Olsson AG, Pedersen TJ, Jönsson B; IDEAL Trial Investigators. Lindgren P, et al. Eur Heart J. 2007 Jun;28(12):1448-53. doi: 10.1093/eurheartj/ehm020. Epub 2007 Mar 19. Eur Heart J. 2007. PMID: 17371782
Cost-effectiveness analysis of rosuvastatin vs generic atorvastatin in Spain.
Barrios V, Lobos JM, Serrano A, Brosa M, Capel M, Alvarez Sanz C. Barrios V, et al. J Med Econ. 2012;15 Suppl 1:45-54. doi: 10.3111/13696998.2012.726674. Epub 2012 Sep 12. J Med Econ. 2012. PMID: 22954062
158 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback